Related Experiment Video
Updated: Jun 24, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
[Stroke and hypertension]
1Medizinische Klinik, St.-Josefs-Hospital, Krankenhausstrasse 13, Cloppenburg, Germany. j.schrader@kh-clp.de
Insights
Effective antihypertensive therapy is crucial for stroke prevention, often requiring drug combinations to achieve normotension. Early treatment also helps prevent vascular dementia and cognitive decline.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Context:
- Arterial hypertension is a leading risk factor for stroke.
- Antihypertensive therapy is proven effective in primary and secondary stroke prevention across all age groups.
- Achieving normotension is paramount, often necessitating combination drug therapy.
Purpose:
- To review the efficacy of antihypertensive therapies in stroke prevention.
- To discuss optimal drug choices for different patient populations and risk factors.
- To highlight the importance of ambulatory blood pressure monitoring and the link between hypertension and cognitive decline.
Summary:
- No single antihypertensive agent is recommended for primary stroke prevention; achieving target blood pressure is key.
- For high-risk patients and secondary prevention, renin-angiotensin-system inhibitors combined with calcium antagonists and indapamide may be preferred over beta-blockers.
- Sartans are well-documented for patients with left-ventricular hypertrophy or atrial fibrillation.
- Ambulatory 24-hour blood pressure monitoring is essential to assess therapeutic outcomes, especially given disrupted circadian rhythms post-stroke.
- Hypertension is causally linked to vascular dementia; early treatment can prevent cognitive impairment.
Impact:
- Provides evidence-based guidance on antihypertensive drug selection for stroke prevention.
- Emphasizes the role of combination therapy and specific drug classes in managing hypertension.
- Underscores the importance of continuous blood pressure monitoring and the neuroprotective effects of antihypertensive treatment.
Abstract:
Arterial hypertension is the most important risk factor for stroke. Many interventional trials have unambiguously proven the benefit of antihypertensive therapy in both primary and secondary prevention for all age categories. No recommendation for any single antihypertensive substance for the primary prevention of stroke exists. Achieving the therapeutic goal (normotension) is the crucial factor. In most patients, multiple combinations of antihypertensive drugs are required to do this. For high-risk patients and in secondary prevention, substances inhibiting the renin-angiotensin-system, especially combined with calcium antagonists and indapamid, may be advantageous, while beta-blockers appear to be less well suited. In patients suffering from left-ventricular hypertrophy or atrial fibrillation, sartanes are the best-documented drug class. As TIA or stroke will often disturb the normal circadian rhythm of blood pressure and eliminate the usual night-time drop, monitoring of the therapeutic results must include ambulatory 24h measurements. The interrelation between vascular dementia and hypertension is by now also considered proven. An early start of antihypertensive treatment can prevent the development of dementia and impaired cognitive function.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Stroke: Introduction and Types
Hemorrhagic Stroke l: Introduction
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...